a Department of Surgery, University of California, Irvine Medical Center, Orange, CA
b Department of Surgery, Beth Israel Medical Center, New York, NY
c Department of Surgery, University of California San Diego Medical Center, La Jolla, CA
d Department of Surgery, Maimonides Medical Center, Brooklyn, NY
e Department of Surgery, New York Presbyterian Hospital, Weill Cornell Medical Center, New York, NY
f Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, FL
g Department of Colon and Rectal Surgery, Ochsner Clinic Foundation, New Orleans, LA
h Surgical Disciplines, Central Michigan University, College of Medicine, Saginaw, MI
*Correspondence address: Michael J Stamos, MD, FACS, Department of Surgery, University of California, Irvine, 333 City Blvd. West Suite 1600, Orange, CA 92868.
E-mail: [email protected]
Received May 31, 2014; revised September 11, 2014; accepted September 11, 2014.
Disclosure Information: Drs Wexner, McLemore, Sherwinter, and Stamos are paid consultants and speakers for Novadaq Technologies Inc. The study is fully funded by Novadaq Technologies Inc. All other authors have nothing to disclose.
Disclosures outside the scope of the current work: Dr Lee provided expert testimony for Covidien and is paid as a speaker by Applied Medical; Dr McLemore is a paid consultant for Covidien and Intuitive Surgical, received grants from Applied Medical, Covidien, and Stryker, received pay as a speaker for Applied Medical, Ethicon EndoSurgery, Cubist, Genomic Health, Covidien, and Novadaq, and owns stock in Cubist.
